Skip to main content

Published locations for Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide

User login

  • Reset your password
  • /content/ofatumumab-has-superior-efficacy-relapsing-remitting-ms-compared-teriflunomide
  • /neurologyreviews/article/208167/multiple-sclerosis/ofatumumab-has-superior-efficacy-relapsing
  • /multiplesclerosishub/article/208167/multiple-sclerosis/ofatumumab-has-superior-efficacy-relapsing
  • /neurology/article/208167/multiple-sclerosis/ofatumumab-has-superior-efficacy-relapsing-remitting-ms
  • /neurology/msresourcecenter/article/208167/multiple-sclerosis/ofatumumab-has-superior-efficacy
  • /clinicalneurologynews/article/208167/multiple-sclerosis/ofatumumab-has-superior-efficacy-relapsing